Identification of genetic events that lead to breast cancer can pave the way for developing personalized treatments to overcome the disease.

TOP INSIGHT
British Researchers identify 93 genes that are associated with breast cancer and targeting these genetic mutations can help in developing personalized breast cancer treatments.
Examining more into this 93 faulty genes and targeting them for drug development could help in developing personalized breast cancer treatments.
These 93 genes are said to be crucial as they put a person at an higher risk of developing breast cancer. The team hope that they will be able to tailor treatment to the genetic make-up of the individual. The findings were published in the Journal Nature Communications.
Professor Sir Mike Stratton, director of the Wellcome Trust Sanger Institute, said, "This huge study, examining in great detail the many thousands of mutations present in each of the genomes of 560 cases brings us much closer to a complete description of the changes in DNA in breast cancer and thus to a comprehensive understanding of the causes of the disease and the opportunities for new treatments."
Source-Medindia
MEDINDIA




Email










